Amanda Sweitzer
Stock Analyst at Baird
(1.71)
# 3,414
Out of 5,245 analysts
27
Total ratings
37.5%
Success rate
2.54%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Amanda Sweitzer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DOC Healthpeak Properties | Maintains: Outperform | $19 → $21 | $19.73 | +6.44% | 8 | May 13, 2026 | |
| CHCT Community Healthcare Trust | Maintains: Neutral | $29 → $25 | $17.38 | +43.84% | 2 | Jul 31, 2024 | |
| WELL Welltower | Maintains: Neutral | $80 → $84 | $216.17 | -61.14% | 6 | Sep 14, 2023 | |
| VTR Ventas | Downgrades: Neutral | n/a | $88.18 | - | 5 | Oct 10, 2022 | |
| OHI Omega Healthcare Investors | Downgrades: Neutral | n/a | $47.90 | - | 2 | Oct 10, 2022 | |
| KRC Kilroy Realty | Downgrades: Neutral | n/a | $33.97 | - | 1 | Oct 10, 2022 | |
| CTRE CareTrust REIT | Initiates: Outperform | $23 | $41.14 | -44.09% | 1 | Oct 8, 2021 | |
| MAA Mid-America Apartment Communities | Downgrades: Neutral | $132 → $137 | $131.14 | +4.47% | 1 | Feb 9, 2021 | |
| CPT Camden Property Trust | Upgrades: Outperform | $109 | $107.47 | +1.42% | 1 | Feb 9, 2021 |
Healthpeak Properties
May 13, 2026
Maintains: Outperform
Price Target: $19 → $21
Current: $19.73
Upside: +6.44%
Community Healthcare Trust
Jul 31, 2024
Maintains: Neutral
Price Target: $29 → $25
Current: $17.38
Upside: +43.84%
Welltower
Sep 14, 2023
Maintains: Neutral
Price Target: $80 → $84
Current: $216.17
Upside: -61.14%
Ventas
Oct 10, 2022
Downgrades: Neutral
Price Target: n/a
Current: $88.18
Upside: -
Omega Healthcare Investors
Oct 10, 2022
Downgrades: Neutral
Price Target: n/a
Current: $47.90
Upside: -
Kilroy Realty
Oct 10, 2022
Downgrades: Neutral
Price Target: n/a
Current: $33.97
Upside: -
CareTrust REIT
Oct 8, 2021
Initiates: Outperform
Price Target: $23
Current: $41.14
Upside: -44.09%
Mid-America Apartment Communities
Feb 9, 2021
Downgrades: Neutral
Price Target: $132 → $137
Current: $131.14
Upside: +4.47%
Camden Property Trust
Feb 9, 2021
Upgrades: Outperform
Price Target: $109
Current: $107.47
Upside: +1.42%